Zai Lab Q2 revenue falls to $106.3 million as net loss widens to $50.8 million
Zai Lab reported second-quarter 2026 total revenue of $106.3 million, down from $110.0 million a year earlier, while its net loss widened to $50.8 million from $40.7 million. The company said the higher loss was primarily due to higher licensing fees, which lifted research and development expenses to $61.8 million from $50.6 million. Cash, short-term investments and current restricted cash totaled $717.5 million at June 30, 2026, down from $761.3 million at March 31, 2026.
Key points
- Total revenue was $106.3 million, compared with $110.0 million in the second quarter of 2025.
- Net loss was $50.8 million, or $0.05 per ordinary share, versus a net loss of $40.7 million, or $0.04 per share, a year earlier.
- Loss from operations was $76.5 million, compared with $54.9 million a year earlier; adjusted loss from operations was $60.4 million.
- Cash and equivalents and related balances totaled $717.5 million at June 30, 2026, versus $761.3 million at March 31, 2026.
The filing
Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.